| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/17/2004 | US20040115252 Methods of treating illnesses in non-human mammals |
| 06/17/2004 | US20040115244 Methods and compositions for nicotine replacement therapy |
| 06/17/2004 | US20040115243 Compositions for oral delivery of nutrients and pharmaceuticals |
| 06/17/2004 | US20040115236 implantable sustained-release dosage form comprising a drug delivery device and an inhibitor of mast cell-mediated inflammation such as chromene |
| 06/17/2004 | US20040115233 Composition for improving skin environment and clothes thereof |
| 06/17/2004 | US20040115229 adhesive composition comprising at least one NCO-terminated hydrophilic urethane prepolymer; applying the adhesive composition over a defect in lung tissue |
| 06/17/2004 | US20040115228 comprising a viscosity enhancer polymer Aculyn 44 (TM) |
| 06/17/2004 | US20040115227 Thermoformable solid pharmaceutical composition for controlled release of perindopril |
| 06/17/2004 | US20040115226 Free-flowing solid formulations with improved bio-availability of poorly water soluble drugs and process for making the same |
| 06/17/2004 | US20040115225 charcoal, an alkyl acrylate copolymer, and/or an alpha -hydroxy acid; can eliminate unnecessary horny cells without giving irritation or damage to the skin |
| 06/17/2004 | US20040115223 Prevention and treatment of allergies by helminthic regulation of IgE |
| 06/17/2004 | US20040115192 a site-specific targeting ligand; a lipid encapsulated oil in water emulsion; and a bioactive agent in or on the surface of the outer monolayer of the emulsion; the ligand being conjugated directly or indirectly to the emulsion |
| 06/17/2004 | US20040115185 Placental alkaline phosphatase to control diabetes |
| 06/17/2004 | US20040115184 Methods and compositions for modifying apolipoprotein b mrna editing |
| 06/17/2004 | US20040115181 Composition for transmucosal adminstration containing conenzyme q as the active ingredient |
| 06/17/2004 | US20040115179 treating and preventing gastrointestinal diseases as well as lowering serum cholesterol |
| 06/17/2004 | US20040115167 applied to the skin of a living animal, causing the microprojections to pierce the stratum corneum and to deliver an effective dose of the biologically active agent and vasoconstrictor to the animal. |
| 06/17/2004 | US20040115164 Soft filament occlusive device delivery system |
| 06/17/2004 | US20040115148 crosslinked copolymers of acryloyldimethyltaurine |
| 06/17/2004 | US20040115137 Water-soluble film for oral administration |
| 06/17/2004 | US20040115136 L-tartrate derivative; stable particle size distribution; reproducible dosing; can be stored under varying temperature and humidity conditions |
| 06/17/2004 | US20040115135 Bioavailability; side effect reduction |
| 06/17/2004 | US20040115134 Novel nifedipine compositions |
| 06/17/2004 | US20040115133 High bioavailability pain relief; masking agent for easier delivery; nose spray |
| 06/17/2004 | US20040115128 Targeting endothelium for tissue-specific delivery of agents |
| 06/17/2004 | US20040113319 including wood fiber based core, a decorative surface layer that includes a thermosetting resin, and aluminium oxide, by mechanical cutting of panel into particles, mixing particles with a melamine formaldehyde binder, and pressing mixed particles and binder and thereby forming sheet shaped material |
| 06/17/2004 | US20040112719 Extendable belt conveyor |
| 06/17/2004 | US20040112376 Method of inducing euglycemia in diabetic patients |
| 06/17/2004 | DE20220901U1 Film coating composition for controlled release of active ingredient e.g. metoprolol, comprises an acrylic polymer dispersion, a surfactant, sodium stearyl fumarate and a water-containing liquid |
| 06/17/2004 | DE10255554A1 Emulgator-Wachs-Gele auf Wasserbasis Emulsifier wax gels, water-based |
| 06/17/2004 | DE10255217A1 Homeopathic medicament for treating mental suffering conditions, e.g. grief, comprising tears subjected to homeopathic dilution and incorporated in dosage form |
| 06/17/2004 | CA2791165A1 A conjugate comprising cholesterol linked to tetracycline |
| 06/17/2004 | CA2508536A1 An exopolysaccharides delivery system for active molecules |
| 06/17/2004 | CA2508301A1 Low viscosity liquid dosage forms |
| 06/17/2004 | CA2508034A1 Quaternary compounds comprising propolis as the active substance |
| 06/17/2004 | CA2507848A1 Ifosfamide compositions for parenteral administration and a process for their preparation |
| 06/17/2004 | CA2507815A1 High enantiomeric purity dexanabinol for pharmaceutical compositions |
| 06/17/2004 | CA2507769A1 Density-controlled particulate suspensions for foodstuff, cosmetic, pharmaceutical and other uses |
| 06/17/2004 | CA2507762A1 Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier |
| 06/17/2004 | CA2507748A1 Pharmaceutical formulations comprising .beta.-2 adrenoreceptor agonists and xanthines |
| 06/17/2004 | CA2507609A1 Method and compositions for treating anxiety |
| 06/17/2004 | CA2507036A1 Materials and methods for treating ocular-related disorders |
| 06/17/2004 | CA2505298A1 Methods and compositions for applying pharmacologic agents to the ear |
| 06/17/2004 | CA2505106A1 Concentrated liquid valdecoxib composition |
| 06/17/2004 | CA2504814A1 Process for producing edible orally administered agent of laminate film form and compression bonding apparatus |
| 06/17/2004 | CA2504801A1 Pharmaceutical compositions of cell lysate and processes for the production and use thereof |
| 06/16/2004 | EP1428571A1 Microcapsules (XX) |
| 06/16/2004 | EP1428535A1 Controlled delivery of antidepressants |
| 06/16/2004 | EP1428527A1 Novel formulations for transdermal delivery of pergolide |
| 06/16/2004 | EP1428526A1 Formulation for fast dissolution of lipophilic compounds |
| 06/16/2004 | EP1428525A1 Pharmaceutical preparations for the veterinary use containing acetylsalicylic acid in the form of buffered soluble powder |
| 06/16/2004 | EP1428524A1 Pulmonary delivery of aerosolized medicaments |
| 06/16/2004 | EP1427848A2 Dry solid medium for storage and analysis of genetic material |
| 06/16/2004 | EP1427806A2 Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof |
| 06/16/2004 | EP1427717A1 Bioprecursors for percutaneous application |
| 06/16/2004 | EP1427464A2 Drug delivery technology |
| 06/16/2004 | EP1427454A1 Microtubes for therapeutic delivery |
| 06/16/2004 | EP1427449A1 Anti-cancer agents comprising disintegrin genes and the treating methods |
| 06/16/2004 | EP1427447A1 Improved therapeutic protocols |
| 06/16/2004 | EP1427446A2 The use of effect pigments in ingested drugs |
| 06/16/2004 | EP1427444A2 West nile vaccine |
| 06/16/2004 | EP1427436A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection |
| 06/16/2004 | EP1427433A1 Biodegradable implant comprising a polylactide polymer and a lh-rh analogue |
| 06/16/2004 | EP1427431A2 Bioadhesive compositions and methods for enhanced mucosal drug absorption |
| 06/16/2004 | EP1427419A1 Improvement of the local compatibility during intravenous administration of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluormethyl-benzoylguanidine |
| 06/16/2004 | EP1427414A1 Inhalation compositions comprising tricyclic 5,6-dihydro-9h-pyrazolo (3,4-c)-1,2,4-triazolo (4,3-alpha) pyridines |
| 06/16/2004 | EP1427411A2 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo 3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 06/16/2004 | EP1427405A2 Inflammation-inhibiting compounds |
| 06/16/2004 | EP1427400A2 Triclosan dosage form |
| 06/16/2004 | EP1427398A1 Device for the administration of an active agent to the human skin |
| 06/16/2004 | EP1427397A1 Oily thixotropic formulations |
| 06/16/2004 | EP1427396A1 Dosage forms having prolonged active ingredient release |
| 06/16/2004 | EP1427395A1 Stabilization of active agents by formulation into nanoparticulate form |
| 06/16/2004 | EP1427394A1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities |
| 06/16/2004 | EP1427393A2 Liposomes containing active substances |
| 06/16/2004 | EP1427392A1 New self emulsifying drug delivery system |
| 06/16/2004 | EP1427391A1 Vascular occlusion solid-phase agent with immobilised platelet binding agent |
| 06/16/2004 | EP1427390A1 Drug delivery system |
| 06/16/2004 | EP1427380A1 Fluid-to-powder compositions |
| 06/16/2004 | EP1427366A2 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy |
| 06/16/2004 | EP1427325A2 Management of gastro-intestinal disorders |
| 06/16/2004 | EP1427292A1 Chewing gum in powder form and a method of preparation |
| 06/16/2004 | EP1427289A2 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 06/16/2004 | EP1380639A4 Method for producing a water-alcohol solution and products based thereon |
| 06/16/2004 | EP1294413B1 Sprayable wound care compositions |
| 06/16/2004 | EP1294364A4 Stable gabapentin having ph within a controlled range |
| 06/16/2004 | EP1267833B1 Pharmaceutical preparations and their manufacture |
| 06/16/2004 | EP1265698B1 Lipid nanocapsules, preparation method and use as medicine |
| 06/16/2004 | EP1263922B1 Method for producing moulded bodies |
| 06/16/2004 | EP1233772A4 Boron compounds and complexes as anti-inflammatory agents |
| 06/16/2004 | EP1224715A4 Coaxial connector having detachable locking sleeve |
| 06/16/2004 | EP1214075B1 POLYMORPHS OF N-METHYL-N-(3- 3- 2-THIENYLCARBONYL]-PYRAZOL- 1,5-$g(a)]-PYRIMIDIN-7-YL PHENYL)ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO |
| 06/16/2004 | EP1204417B1 Parenteral cisplatin emulsion |
| 06/16/2004 | EP1200096B1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 06/16/2004 | EP1194132B1 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 06/16/2004 | EP1187539A4 Method and composition for masking mineral taste |
| 06/16/2004 | EP1165044B1 High potency dihydroergotamine compositions |
| 06/16/2004 | EP1140068B1 Doramectin formulations |
| 06/16/2004 | EP1140032B1 A pharmaceutical mixture comprising a profen |
| 06/16/2004 | EP1126881B1 Muco-adhesive polymers, use thereof and method for producing the same |